Cargando…
Differences in MPS I and MPS II Disease Manifestations
Mucopolysaccharidosis (MPS) type I and II are two closely related lysosomal storage diseases associated with disrupted glycosaminoglycan catabolism. In MPS II, the first step of degradation of heparan sulfate (HS) and dermatan sulfate (DS) is blocked by a deficiency in the lysosomal enzyme iduronate...
Autores principales: | Hampe, Christiane S., Yund, Brianna D., Orchard, Paul J., Lund, Troy C., Wesley, Jacob, McIvor, R. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345985/ https://www.ncbi.nlm.nih.gov/pubmed/34360653 http://dx.doi.org/10.3390/ijms22157888 |
Ejemplares similares
-
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
por: Hampe, Christiane S., et al.
Publicado: (2020) -
The impact of COVID-19 on Brazilian children with MPS: Advocate group perspective
por: Oliveira, Maria Carolina F.A., et al.
Publicado: (2022) -
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
por: Hampe, Christiane S., et al.
Publicado: (2021) -
The natural history of MPS I: global perspectives from the MPS I Registry
por: Beck, Michael, et al.
Publicado: (2014) -
A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
por: Shapiro, Elsa G., et al.
Publicado: (2016)